Skip to content

Abbott ABT Acquisitions

Acquisitions at other companies

Becton, Dickinson and Company logo
Becton, Dickinson and CompanyBDX
$0+100%
Johnson & Johnson logo
Johnson & JohnsonJNJ
$17.5B
Haemonetics logo
HaemoneticsHAE
$60.18M
Merit Medical Systems logo
Merit Medical SystemsMMSI
$1M0.0%
Boston Scientific logo
Boston ScientificBSX
$523M+119%
Edwards Lifesciences logo
Edwards LifesciencesEW
$6.3M

Other financials

Income statement

See full
Revenue$12.6B+13.0%
Gross profit$7.3B+15.6%
Operating income$1.7B-17.5%
Net income$928.0M-47.8%
EPS (diluted)$0.53-47.5%

Balance sheet

See full
Cash & equivalents$5.1B-26.6%
Total debt$32.6B+143%
Total equity$51.1B+1.1%
Total assets$109.22B+30.0%

Cash flow

See full
Operating cash flow$2.5B+21.5%
CapEx$497.0M-1.0%
Free cash flow$2.0B+28.9%

Valuation

See full
Market cap$186.88B-16.4%
Enterprise value$214.39B-6.8%
P/E34.5×+18.4×
P/S-1.2×

Profitability

See full
Gross margin56.6%+0.6pp
Operating margin15.8%-1.7pp
Net margin11.6%-20.8pp
FCF margin16.8%+1.1pp

Returns & leverage

See full
Return on equity10.7%-20.4pp
Debt / equity0.6×+0.4×
Current ratio1.4×-0.4×

Where this comes from

Reported directly by Abbott in its filing.

Tagged under the XBRL concept abt:PaymentsToAcquireBusinessesNetOfCashAcquiredAndResearchAndDevelopmentInProcess.

The official record: Abbott’s 10-K, filed February 20, 2026, on SEC EDGAR. View the filing →

Ask your AI about Abbott's acquisitions.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Abbott's acquisitions?
Abbott (ABT) reported acquisitions of $20M in Q4 2025.
What does acquisitions mean?
Cash paid for business acquisitions net of cash acquired in the target company — the primary M&A cash flow line.